Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT02292043 |
Date of registration:
|
31/10/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction
|
Scientific title:
|
Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction |
Date of first enrolment:
|
May 2013 |
Target sample size:
|
60 |
Recruitment status: |
Recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT02292043 |
Study type:
|
Observational |
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
wei liu |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
First Affiliated Hospital of Harbin Medical University |
|
Name:
|
wei liu, Ph.D. |
Address:
|
|
Telephone:
|
86-18904502999 |
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- 90 chronic cardiac failure patients in our hospital were selected and divided into
two groups.
Exclusion Criteria:
- Vavular diseases
Age minimum:
20 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Congestive Heart Failure
|
Intervention(s)
|
Drug: HTEA
|
Primary Outcome(s)
|
Morbidity
[Time Frame: 1 months to 3 months after discharge]
|
Secondary Outcome(s)
|
The decreased degree of NT-proBNP higher than 30%
[Time Frame: 3 months after discharge]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|